| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020137 |
| Receipt No. | R000023260 |
| Official scientific title of the study | Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study |
| Date of disclosure of the study information | 2015/12/09 |
| Last modified on | 2016/09/01 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study | |
| Title of the study (Brief title) | Improvement of joint pain and safety by ingestion of supplement containing glucosamine | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to evaluate improvement of joint pain (in knee, elbow, and back), and safety by ingestion of supplement containing glucosamine consecutively on healthy adult. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 2-step test (locomotion test), subjective evaluation (J-KOOS, JKOM, HAQ, ODI) <before and after ingestion of supplement for 16 weeks> |
| Key secondary outcomes | safety <before and after ingestion of supplement for 16 weeks> |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake test sample for 16 weeks | |
| Interventions/Control_2 | Intake placebo for 16 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Male and female between 30 and 69 years of age | |||
| Key exclusion criteria | 1. Subjects with joint pain caused by gout or rheumatism
2. Subjects with surgical experience for knee or elbow 3. Subjects with a history of fracture or sprain within the past 3 months 4. Subject with a past history of diseases in heart, kidney, liver, digestive organ, blood vessels or metabolism 5. Subjects who consume food or medicinal product containing glucosamine, chondroitin or hyaluronan 6. Subjects with food allergies 7. Subjects who are pregnant or lactating 8. Subjects who are judged as unsuitable for the study by the investigator for other reasons |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Masatomo Najima |
| Organization | Japan clinical trial association |
| Division name | N.A. |
| Address | 8F, 5-27-3 sendagaya, shibuyaku, Tokyo |
| TEL | 03-6457-4666 |
| info@yakujihou.org | |
| Public contact | |
| Name of contact person | Hirohisa Kojima |
| Organization | Japan clinical trial association |
| Division name | N.A. |
| Address | 8F, 5-27-3 sendagaya, shibuyaku, Tokyo |
| TEL | 03-6457-4666 |
| Homepage URL | |
| info@yakujihou.org | |
| Sponsor | |
| Institute | Japan clinical trial association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yawata Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023260 |